(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIVLION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VIVLION

ST13

US500000088024102

Class

1, 5, 42

Filing

88024102

Registration

5906320

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

03/12/2026

Trademark type

Word

Nice classes

1, 5, 42

Filing date

07/03/2018

Registration date

11/12/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/11/2026

Last transaction

03/12/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

16

Owner location

FRANKFURT AM MAIN, DE

Examiner

KUMIS, SCOTT N

Current location

Historical data usage

Holders and representatives

Holders

VIVLION GMBH
D. K. (pessoa física)

Representatives

Daniel A. Grossman ZVMLaw PLLC

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for scientific use; chemical preparations for scientific and research purposes; biological preparations for scientific research purposes; biochemical products for scientific use in vivo and in vitro

Class 5

Biological preparations for the treatment of cancerneurodegenerationimmunologic diseasescardiovascular diseasesmetabolic diseasesinfectionsmental diseases and respiratory diseases for medical purposes; biochemical preparations for the treatment of cancerneurodegenerationimmunologic diseasescardiovascular diseasesmetabolic diseasesinfectionsmental diseases and respiratory diseases for medical purposes; chemical reagents for medical purposes; biotechnological preparations for the treatment of cancerneurodegenerationimmunologic diseasescardiovascular diseasesmetabolic diseasesinfectionsmental diseases and respiratory diseases for medical purposes; diagnostic agentspreparations and substances for medical purposes; diagnostic reagents for medical purposes; nucleic acid sequences for medical purposes; pharmaceutical preparationstherapeutic medicines and substances for the treatment of cancerneurodegenerationimmunologic diseasescardiovascular diseasesmetabolic diseasesinfectionsmental diseases and respiratory diseases; nucleoside-containing pharmaceutical preparationsantivirals for scientific biomedical purposes

Class 42

Research and development services for the pharmaceutical industry; research and development services for the biotechnology sector; scientific researchtesting and analysis services in the field of pharmaceuticals; laboratory research services in the field of pharmaceuticals; advisory services relating to technical and scientific analysis of pharmaceuticals; technical and scientific analysis in the field of pharmaceuticals; biomedical research; pharmaceutical research and development; scientific research for medical purposes; scientific research in the nature of analysis of large datasets relating to data connectivitytargeted data search; Provision of information and data relating to medical and veterinary research and development in the field of pharmaceuticals; Provision of information and data relating to scientific and technological research and development in the field of pharmaceuticals; computer aided scientific research analysis; Provision of online scientific information for industrial analysis and research in the field of pharmaceuticals; preparation of biological samples for scientific testing and analysis in research laboratories

Publications

History of USPTO decisions and trademark events.

44 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/11/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/11/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2026

ES8R

TEAS SECTION 8 RECEIVED

10/21/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/20/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/20/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/20/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/20/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/20/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/20/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

09/20/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/29/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/12/2019

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/04/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/04/2019

IUCN

NOTICE OF ALLOWANCE CANCELLED

08/27/2019

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

08/27/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/26/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/26/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/16/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/19/2019

PUBO

PUBLISHED FOR OPPOSITION

02/19/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/30/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/15/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

01/15/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/15/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

01/15/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2018

ALIE

ASSIGNED TO LIE

12/12/2018

DOCK

ASSIGNED TO EXAMINER

12/11/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/10/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/21/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/21/2018

ALIE

ASSIGNED TO LIE

11/21/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/09/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/24/2018

GNRT

NON-FINAL ACTION E-MAILED

10/24/2018

CNRT

NON-FINAL ACTION WRITTEN

10/24/2018

DOCK

ASSIGNED TO EXAMINER

10/24/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/09/2018

NWAP

NEW APPLICATION ENTERED

07/06/2018

Continuous trademark protection

Get notified about every new filing that threatens VIVLION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.